1. Evaluating the benefits and adverse effects of an enthracycline-taxane-capecitabine combined regimen in patients with early breast cancer
   Jiantang Zhang et al, 2017, Oncotarget CrossRef
2. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification
   Fouzia Guestini et al, 2016, Expert Opinion on Therapeutic Targets CrossRef